Advertisement

Person › Details
David Dible (Citigate Dewe Rogerson Ltd.)
Dible, David (Huntsworth 201506 Senior Director Life Sciences at Citigate Dewe Rogerson London)
![]() |
Organisation | Citigate Dewe Rogerson Ltd. |
Group | Inizio (Group) | |
![]() |
Product | public relations / investor relations / marcom (services) |
Record changed: 2023-08-02 |
Advertisement

More documents for David Dible
- [1] Molecure S.A.. (7/21/23). "Press Release: Molecure Completes Successful Secondary Public Offering (SPO) of approximately PLN 50 Million (USD 12 Million)". Warsaw....
- [2] Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg....
- [3] Green Bioactives Ltd.. (10/24/22). "Press Release: Green Bioactives Appoints David McElroy as CEO ". Edinburgh....
- [4] Actimed Therapeutics Ltd.. (6/10/21). "Press Release: Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round". London....
- [5] Nordic Nanovector ASA. (2/23/21). "Press Release: Nordic Nanovector Launches a Private Placement of New Shares[Not for US, CA, JP or AU]". Oslo....
- [6] Transgene S.A.. (6/14/19). "Press Release: Transgene Launches a Rights Issue for an Amount of up to €50 Million [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top